Dharti Proteins Ltd Approves Unaudited Financial Results for Quarter Ended June 30, 2026
Dharti Proteins Limited (formerly Devika Proteins Limited) has announced the approval of its unaudited standalone financial results for the quarter ended June 30, 2026. The Board meeting was held on July 15, 2026, and the results were reviewed by the company's Audit Committee before being approved by the Board of Directors.The results were subjected to a Limited Review Report from Chartered Accountants N.S. Nanavati & Co., who issued a declaration stating that the accompanying statement did not contain any material misstatement and was prepared in accordance with applicable Indian Accounting Standards (Ind AS).
The company's unaudited financial statements cover various operational metrics, including revenue, expenses, and profit before tax for the quarter. The results were reviewed by statutory auditors as per regulations regarding interim financial reporting.
Key figures from the standalone unaudited statement of financial results are presented below:
| Particulars | Quarter Ended 30 June, 2026 (Unaudited) | Previous Year Ended (Audited) |
|---|---|---|
| Total Revenue | 0.05 | 2.97 |
| Other Income | 0.04 | 2.97 |
| Profit before Tax | (14.28) | (4.50) |
| Net Profit for the Period | (14.28) | (84.65) |
The company confirmed that the figures for the earlier periods have been regrouped as necessary. The Financial Results, along with the Limited Review Report, provide a comprehensive overview of the company's financial standing for the specified quarter.
Stock Price Movement
As of 15:18, shares of Dharti Proteins Ltd are trading at ₹3.45, maintaining a zero percent change. The stock is currently locked and trading completely flat, holding steady within its intraday range.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.